Why is Jaguar Health, Inc. ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Low ability to service debt as the company has a high Debt to EBITDA ratio of -1.01 times
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -99.37%, its profits have fallen by -4.6%
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -99.37% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Jaguar Health, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Jaguar Health, Inc.
-99.37%
0.02
3459.37%
S&P 500
16.06%
1.22
13.16%
Quality key factors
Factor
Value
Sales Growth (5y)
7.22%
EBIT Growth (5y)
-4.43%
EBIT to Interest (avg)
-10.45
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
7.42
Sales to Capital Employed (avg)
0.26
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
7.92%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.23
EV to EBIT
-0.88
EV to EBITDA
-0.94
EV to Capital Employed
0.87
EV to Sales
2.44
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-99.22%
ROE (Latest)
-567.44%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bearish
Technical Movement
22What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -6.69 MM
NET SALES(HY)
Higher at USD 21.5 MM
NET PROFIT(HY)
Higher at USD 2.55 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 0.77 times
DEBTORS TURNOVER RATIO(HY)
Highest at 36.74 times
-9What is not working for the Company
INTEREST(9M)
At USD 0.86 MM has Grown at inf%
RAW MATERIAL COST(Y)
Grown by 136.78% (YoY
NET SALES(Q)
Lowest at USD 1.23 MM
Here's what is working for Jaguar Health, Inc.
Net Profit
At USD 2.55 MM has Grown at 115.35%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD -6.69 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Profit
Higher at USD 2.55 MM
than preceding 12 month period ended Jun 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Inventory Turnover Ratio
Highest at 0.77 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 36.74 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Jaguar Health, Inc.
Interest
At USD 0.86 MM has Grown at inf%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Net Sales
At USD 1.23 MM has Fallen at -83.43%
over average net sales of the previous four periods of USD 7.39 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Net Sales
Lowest at USD 1.23 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Raw Material Cost
Grown by 136.78% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Footer loading






